Musculoskeletal problems in persons with inhibitors: How do we treat?

Haemophilia

Volumn 18, Issue SUPPL.4, 2012, Pages 54-60

  Caviglia, H ^a   Narayan, P ^b   Forsyth, A ^c   Giangrande, P ^d   Gilbert, M ^e   Goddard, N ^f   Mulder, K ^b   Rahim, S ^g  

^a HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^b Christiana Care Health System Hemophilia Program ^*

^c CHRISTIANA CARE HEALTH SYSTEM   (United States)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e Royal Free Hospital   (United States)

^f ROYAL FREE HOSPITAL   (United Kingdom)

^g RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

Author keywords

Haemophilia; Inhibitors; Orthopaedic surgery; Physiotherapy

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; BLOOD CLOTTING INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ABSENTEEISM; ARGENTINA; ARTICLE; CONSERVATIVE TREATMENT; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; EARLY INTERVENTION; HEALTH CARE ACCESS; HEALTH CARE COST; HEMOPHILIA; HUMAN; INTERDISCIPLINARY COMMUNICATION; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; MUSCLE BLEEDING; MUSCULOSKELETAL DISEASE; ORTHOPEDIC SURGEON; PHYSIOTHERAPIST; PHYSIOTHERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCREENING; SHORT FORM 36; THROMBOSIS; TREATMENT PLANNING;

BLOOD COAGULATION FACTOR INHIBITORS; COAGULANTS; FACTOR VII; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGE; HUMANS; MUSCULOSKELETAL DISEASES; ORTHOPEDIC PROCEDURES; PHYSICAL THERAPY MODALITIES;

EID: 84862835687     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02874.x     Document Type: Article

References (40)

1. Dimichele D. Inhibitors: resolving diagnostic and therapeutic dilemmas. Haemophilia 2002; 8: 280-7.
2. Careri D. Personal Communication. Presented in Novo Nordysk International Symposium, Barcelona 2007.
3. Darby SC, Keeling DM, Spooner RJD, Giangrande PLF, Collins PW, Hill FG. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. J Thromb Haemost 2004; 2: 1047-54.
4. Aledort LM. Comparitive thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. J Thromb Haemost 2004; 2: 1700-8.
5. Abshire T, Kenet G. Safety update on the use of recombinant activated factor VII and the treatment of congenital and acquired deficiency of factor VIII or IX and inhibitors. Haemophilia 2008; 14: 898-902.
6. Astermark J. Immune tolerance induction in patients with haemophilia A. Thromb Res 2011; 127: S6-9.
7. Benson G, Auerswald G, Elezovic I, et al. Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice. Eur J Haematol 2012; (in press).
8. Chitlur M, Warrier I, Rajpurkar M, Lusher JM. Inhibitors in factor IX deficiency. A report of the ISTH-SSC international FIX inhibitor registry (1997-2006). Haemophilia 2009; 15: 1027-31.
9. Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P. The French FEIBA Study Group. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. Thromb Haemost 1997; 77: 1113-9.
10. Obergfell A, Auvinen M-K, Mathew P. Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature. Haemophilia 2008; 14: 233-41.
11. Sahrmann SA. Diagnosis and Treatment of Movement Impairment Syndromes. St Louis, MO: Mosby, 2001.
12. Morfini M, Haya S, Tagariello G et al. European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia 2007; 13: 606-12.
13. Jiménez-Yuste V, Rodriguez-Merchan EC, Alvarez MT, Quintana M, Fernandez I, Hernandez-Navarro F. Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors. Semin Hematol 2003; 45: S64-7.
14. Caviglia H, Candela M, Galatro G, Neme D, Moretti N, Bianco RP. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature. Haemophilia 2011; j.1365-2516.011.02504.x. doi:10.1111/j.1365-2516.2011.x. 2011 Nov;17(6):910-9. doi: 10.1111/j.1365-2516.2011.02504.x. Epub 2011 Feb 2215.
15. Rodriguez-Merchan EC, Wiedel JD, Wallny T et al. Elective orthopedic surgery for hemophilia patients with inhibitors: new opportunities. Semin Hematol 2004; 41: 109-16.
16. Hvid I, Rodriguez-Merchan EC. Orthopaedic surgery in haemophilic patients with inhibitors: an overview. Haemophilia 2002; 8: 288-91.
17. Mehta S, Nelson CL, Konkle BA, Vannozzi B. Total knee arthroplasty using recombinant factor VII in hemophilia-A patients with inhibitors: a report of three cases. J Bone Joint Surg Am 2004; 86-A: 2519-21.
18. Hoffman M, Monroe DM. Wound healing in haemophilia, breaking the vicious cycle. Haemophlia 2010; 16: 13-8.
19. Ludlam C. Identifying and managing inhibitor patients requiring orthopaedic surgery - the multidisciplinary team approach. Haemophilia 2005; 11: 7-10.
20. Solimeno LP, Perfetto OS, Pasta G, Santa-gostino E. Total joint replacement in patients with inhibitors. Haemophilia 2006; 12: 113-6.
21. Konkle BA, Nelson C, Forsyth A, Hume E. Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors. Haemophilia 2002; 8: 706-11.
22. Cook JR, Warren M, Ganley KJ, Prefontaine P, Wylie JW. A comprehensive joint replacement program for total knee arthroplasty: a descriptive study. BMC Musculoskelet Disord 2008; 9: 154.
23. Brosseau L, Milne S, Wells GA et al. Efficacy of continuous passive motion following total knee arthroplasty: a metaanalysis. J Rheumatolgy 2004; 31: 2251-64.
24. Denis M, Moffet H, Caron F et al. Effectiveness of continuous passive motion and conventional physical therapy after total knee arthroplasty: a randomized clinical trial. Phys Ther 2006; 86: 174-85.
25. McInnes J, Larson MG, Daltroy LH et al. A controlled evaluation of continuous passive motion in patients undergoing total knee arthroplasty. JAMA 1992; 268: 1423-8.
26. Lenssen TAF, vanSteyn MJA, Crijns YHF et al. Effectiveness of prolonged use of continuous passive motion (CPM), as an adjunct to physiotherapy, after total knee arthroplasty. BMC Musculoskeletal Disorders 2008; 9: 60.
27. Teitel JM, Carcao D, Lillicrap D, Mulder K. Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgery and rehabilitative care. Haemophilia 2009; 15: 227-39.
28. Collins NC. Is ice right? Does cryotherapy improve outcome for acute soft tissue injury? Emerg Med J 2008; 25: 65-8.
29. Sutor AH, Bowie EJW, Owen CA Jr. Effect of cold on bleeding: Hippocrates vidicated. Lancet 1970; Nov 21: 2: 1084.
30. Bahn SL, Mursch PI. The effects of cold on hemostasis. Oral Surg 1980; 49: 294-300.
31. Kattlove H, Alexander B. Effect of cold on bleeding. The Lancet 1970; 2: 1359.
32. Wolberg AS, Meng ZH, Monroe DM, Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 2004; 56: 1221-8.
33. Copley AL, Lalich JJ. Bleeding time, lymph time, and clot resistance in men. J Clin Invest 1942; 21: 145.
34. Rundgren M, Engstrom M. A thromboelastometric evaluation of the effects of hypothermia on the coagulation system. Anesthes Analg 2008; 107: 1465-8.
35. Valeri CR, MacGregor H, Cassidy G, Tinney R, Pompei F. Effects of temperature on bleeding and clotting time in normal male and female volunteers. Crit Care Med 1995; 23: 698-704.
36. Niemczura RT, DePalma RG. Optimum compress temperature for wound hemostasis. J Surg Res 1979; 26: 570-3.
37. Phadke S. Hemophilia care in India: a review and experience from a tertiary care centre in Uttar Pradesh. Indian Journal of Haematology and Blood Transfusion 2011; 27: 121-6.
38. Padkin J. Muscle Imbalance in Haemophilia, in Physiotherapy Management of Haemophilia. (eds B Buzzard and K Beeton), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470757154.ch5.
39. Ballal RD, Botteman MF, Foley I, Stephens JM, Wilke CT, Joshi AV. Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy. Curr Med Res Opin 2008; 24: 753-68.
40. Solimeno LP, Mancuso ME, Pasta G, Santagostino E, Perfetto S and Mannucci PM, Wilke CT. Factors influencing the long-term outcome of primary total knee replacement in haemophiliacs: a review of 116 procedures at a single institution. Br Haematol 2009; 45: 227-34.